Gelonghui, April 23 | Dongbao Biotech (300239.SZ) released its report for the first quarter of 2024. Operating revenue for the reporting period was 242 million yuan, down 7.48% year on year; net profit attributable to shareholders of listed companies was 25.9615 million yuan, down 16.62% year on year; net profit attributable to shareholders of listed companies after deducting non-recurring profit and loss was 236.22,300 yuan, down 21.61% year on year; basic earnings per share were 0.0437 yuan.
东宝生物(300239.SZ)：一季度净利润2596.15万元 同比下降16.62%
Dongbao Biotech (300239.SZ): Net profit of 259.615 million yuan in the first quarter decreased 16.62% year-on-year
The translation is provided by third-party software.
The above content is for informational or educational purposes only and does not constitute any investment advice related to Futu. Although we strive to ensure the truthfulness, accuracy, and originality of all such content, we cannot guarantee it.
Risk Disclaimer
The above content is for informational or educational purposes only and does not constitute any investment advice related to Futu. Although we strive to ensure the truthfulness, accuracy, and originality of all such content, we cannot guarantee it.
Got it
Risk Disclaimer
The above content is for informational or educational purposes only and does not constitute any investment advice related to Futu. Although we strive to ensure the truthfulness, accuracy, and originality of all such content, we cannot guarantee it.
Got it
Statement
This page is machine-translated. Futubull tries to improve but does not guarantee the accuracy and reliability of the translation, and will not be liable for any loss or damage caused by any inaccuracy or omission of the translation.
Write a comment
0 0 0
LikeLoveLaughing CryRespectEmmSadAngry
Tap to Select a Mood
- 分享到weixin
- 分享到qq
- 分享到facebook
- 分享到twitter
- 分享到微博
- 粘贴板
Use the share button in your browser
to share the page with your friends
Tap here to share
No comments yet. Write one.